Xylazine and Other Toxic Adulterants

Dates: September 1, 2026

Meets: Tu from 9:00 AM to 11:15 AM

Location: Zoom Webinar

Zoom - No Charge: $0.00

There are still openings remaining at this time.


Enroll Yourself


Pharmacologically active compounds, impurities, or breakdown products from drug manufacturing and industrial chemicals(collectively referred to as toxic adulterants) have been increasingly detected in the illicit drug supply around the world.

This training activity will discuss the increasing prevalence and dangers of toxic adulterants in the illicit drug supply. The training will discuss the prevalence of various toxic adulterants but will focus on the dangers of the most commonly detected adulterant, xylazine(aka, "tranq"). The training will include the most up-to-date evidence and information regarding xylazine's clinical effects, health impacts, and complications associated with its chronic use and review the most current recommendations for providers to detect and treat xylazine exposure.

Objectives:

  • Describe the pharmacology of xylazine.
  • Recognize the frequent indicators, signs and symptoms, and treatment of xylazine toxicity, overdose, and withdrawal.
  • Discuss the most common clinical effects, health impacts, and complications associated with xylazine use.

Notes:

This event is subject to priority registration. If you have a code, you may register yourself now. If you do not have a registration code, please add yourself to the waitlist. Any registration spots avilable after the priority registration period is over will be awarded on a first-come first-served basis for those on the waitlist.

Certificates for this event are distributed by Hazelden Betty Ford Foundation upon completion of a post-event quiz and evaluation.

If you have any questions about this event, please email learn@midsouth.ualr.edu.

Fee: $0.00
Hours:4.00

Zoom Webinar

Emily Brunner

MD, DFASAM, Physician, TTA Consultant

Dr. Emily Brunner is both certified in family medicine and a distinguished fellow in the field of addiction medicine. She has experience treating addiction in both inpatient and outpatient settings. She is an experienced speaker and specializes in trauma-informed clinical treatment of substance use disorders with a comprehensive and compassionate approach.

Dr. Brunner has been involved in leadership of the Minnesota Society of Addiction Medicine and is now on the national board of the American Society of Addiction Medicine.

Share

Email Information to Friend Print